Established in 1993 by its CEO, M. Jérôme BESSE, GALENIX has emerged as one of the leading companies in Pharmaceutical R&D and Drug Delivery Systems within Europe. GALENIX serves as an excellent strategic partner for pharmaceutical development outsourcing and innovative drug product acquisitions, offering a comprehensive range of services for every phase of pharmaceutical development process including preformulation, analytical development and validation, formulation, scale-up, quality control, ICH stability studies, and registration of drug products. The offerings from GALENIX are adaptable based on the specific needs and requirements of their clients.